Seizing the moment: building Canada’s academic leadership into a commercial powerhouse

Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.

Canada is ranked ninth by the World Intellectual Property Organization, however this success has not translated into growth in domestic commercialization, writes Gordon McCauley, president and CEO of adMare BioInnovations.Photograph by rawpixel.com / Centers for Disease Control and Prevention, distributed under a CC0 1.0 license

Opinion

BY GORDON C. MCCAULEY

September 11, 2023

For years, Canada’s life sciences research community has punched above its weight on a global scale. Over the last few years, tremendous progress has been made to convert that research into innovative companies serving Canadians and the world. We cannot stop now. We are li...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy